A Phase II Study of Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion.
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2013
At a glance
- Drugs Cediranib (Primary)
- Indications Malignant ascites; Malignant pleural effusion
- Focus Therapeutic Use
- 12 Jul 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 10 Apr 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 10 Apr 2012 Actual patient number (12) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History